Rock Springs Capital Management as of Dec. 31, 2016
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 133 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 5.5 | $83M | 614k | 134.48 | |
Alexion Pharmaceuticals | 3.8 | $57M | 465k | 122.35 | |
Aetna | 3.7 | $55M | 441k | 124.01 | |
Merck & Co (MRK) | 3.0 | $44M | 750k | 58.87 | |
Gw Pharmaceuticals Plc ads | 2.7 | $40M | 356k | 111.75 | |
Acadia Healthcare (ACHC) | 2.6 | $38M | 1.2M | 33.10 | |
Allergan | 2.3 | $35M | 166k | 210.01 | |
Radius Health | 2.3 | $35M | 910k | 38.03 | |
CIGNA Corporation | 2.2 | $34M | 252k | 133.39 | |
WellCare Health Plans | 2.1 | $32M | 235k | 137.08 | |
Spark Therapeutics | 2.1 | $31M | 625k | 49.90 | |
Intuitive Surgical (ISRG) | 2.0 | $30M | 48k | 634.17 | |
Aclaris Therapeutics (ACRS) | 2.0 | $30M | 1.1M | 27.14 | |
Ardelyx (ARDX) | 1.9 | $28M | 2.0M | 14.20 | |
Celgene Corporation | 1.9 | $28M | 243k | 115.75 | |
UnitedHealth (UNH) | 1.8 | $26M | 165k | 160.04 | |
Bristol Myers Squibb (BMY) | 1.8 | $26M | 450k | 58.44 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.7 | $25M | 1.6M | 15.57 | |
Advanced Accelerat spon ads each rep 2 ord | 1.7 | $25M | 930k | 26.76 | |
Eli Lilly & Co. (LLY) | 1.6 | $24M | 325k | 73.55 | |
Medicines Company | 1.6 | $24M | 700k | 33.94 | |
Shire | 1.6 | $23M | 137k | 170.38 | |
Pacira Pharmaceuticals (PCRX) | 1.5 | $23M | 713k | 32.30 | |
Gilead Sciences (GILD) | 1.3 | $20M | 277k | 71.61 | |
Theravance Biopharma (TBPH) | 1.3 | $19M | 600k | 31.88 | |
Penumbra (PEN) | 1.3 | $19M | 296k | 63.80 | |
Incyte Corporation (INCY) | 1.1 | $17M | 169k | 100.27 | |
Pra Health Sciences | 1.1 | $17M | 300k | 55.12 | |
Neurocrine Biosciences (NBIX) | 1.1 | $16M | 410k | 38.70 | |
Amarin Corporation (AMRN) | 1.0 | $15M | 5.0M | 3.08 | |
Wright Medical Group Nv | 1.0 | $15M | 667k | 22.98 | |
Prothena (PRTA) | 1.0 | $15M | 310k | 49.19 | |
Amgen (AMGN) | 0.9 | $14M | 97k | 146.21 | |
Coherus Biosciences (CHRS) | 0.9 | $14M | 485k | 28.15 | |
Jazz Pharmaceuticals (JAZZ) | 0.9 | $14M | 124k | 109.03 | |
Galapagos Nv- (GLPG) | 0.9 | $14M | 210k | 64.19 | |
Willis Towers Watson (WTW) | 0.9 | $14M | 110k | 122.28 | |
Biogen Idec (BIIB) | 0.9 | $13M | 47k | 283.57 | |
Walgreen Boots Alliance (WBA) | 0.9 | $13M | 161k | 82.76 | |
Ra Pharmaceuticals | 0.8 | $13M | 826k | 15.19 | |
Danaher Corporation (DHR) | 0.8 | $13M | 160k | 77.84 | |
Patheon N V | 0.8 | $12M | 400k | 28.71 | |
Edwards Lifesciences (EW) | 0.8 | $11M | 121k | 93.70 | |
Ultragenyx Pharmaceutical (RARE) | 0.8 | $11M | 160k | 70.31 | |
Dermira | 0.7 | $11M | 363k | 30.33 | |
Healthsouth | 0.7 | $11M | 265k | 41.24 | |
Hologic (HOLX) | 0.7 | $11M | 265k | 40.12 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $10M | 125k | 82.84 | |
Therapeuticsmd | 0.7 | $9.9M | 1.7M | 5.77 | |
Retrophin | 0.7 | $9.9M | 522k | 18.93 | |
Invitae (NVTAQ) | 0.6 | $9.5M | 1.2M | 7.94 | |
Envision Healthcare | 0.6 | $9.2M | 145k | 63.29 | |
Audentes Therapeutics | 0.6 | $8.9M | 485k | 18.27 | |
Merus N V (MRUS) | 0.6 | $8.4M | 400k | 21.11 | |
Clearside Biomedical (CLSD) | 0.6 | $8.4M | 935k | 8.94 | |
Five Prime Therapeutics | 0.6 | $8.2M | 164k | 50.11 | |
Paratek Pharmaceuticals | 0.5 | $8.1M | 526k | 15.40 | |
Beigene (BGNE) | 0.5 | $8.0M | 265k | 30.36 | |
Regeneron Pharmaceuticals (REGN) | 0.5 | $7.2M | 20k | 367.08 | |
Ligand Pharmaceuticals In (LGND) | 0.5 | $7.1M | 70k | 101.61 | |
Alkermes (ALKS) | 0.5 | $6.9M | 125k | 55.58 | |
Epizyme | 0.5 | $6.9M | 570k | 12.10 | |
Avexis | 0.5 | $6.7M | 140k | 47.73 | |
Egalet Corporation note 5.50% 4/1/20 | 0.5 | $6.8M | 7.8M | 0.87 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.4 | $6.6M | 90k | 73.67 | |
athenahealth | 0.4 | $6.6M | 63k | 105.16 | |
Ascendis Pharma A S (ASND) | 0.4 | $6.6M | 325k | 20.24 | |
Corvus Pharmaceuticals (CRVS) | 0.4 | $6.4M | 450k | 14.30 | |
Insmed (INSM) | 0.4 | $6.2M | 468k | 13.23 | |
RTI Biologics | 0.4 | $6.0M | 1.9M | 3.25 | |
EXACT Sciences Corporation (EXAS) | 0.4 | $6.0M | 451k | 13.36 | |
Aimmune Therapeutics | 0.4 | $6.0M | 293k | 20.45 | |
Achillion Pharmaceuticals | 0.4 | $5.7M | 1.4M | 4.13 | |
Proteostasis Therapeutics In | 0.4 | $5.5M | 450k | 12.26 | |
CHINA CORD Blood Corp | 0.4 | $5.4M | 880k | 6.12 | |
Sarepta Therapeutics (SRPT) | 0.3 | $5.3M | 192k | 27.43 | |
Fibrogen (FGEN) | 0.3 | $5.1M | 240k | 21.40 | |
Clovis Oncology | 0.3 | $4.9M | 110k | 44.42 | |
Medpace Hldgs (MEDP) | 0.3 | $4.9M | 135k | 36.07 | |
Assembly Biosciences | 0.3 | $4.7M | 390k | 12.15 | |
Aduro Biotech | 0.3 | $4.7M | 415k | 11.40 | |
Macrogenics (MGNX) | 0.3 | $4.6M | 225k | 20.44 | |
Steris | 0.3 | $4.4M | 65k | 67.38 | |
Compugen (CGEN) | 0.3 | $4.2M | 825k | 5.10 | |
Intersect Ent | 0.3 | $4.2M | 345k | 12.10 | |
Novadaq Technologies | 0.3 | $3.9M | 555k | 7.09 | |
Allergan Plc pfd conv ser a | 0.3 | $3.8M | 5.0k | 764.00 | |
Amicus Therapeutics (FOLD) | 0.2 | $3.8M | 758k | 4.97 | |
Alder Biopharmaceuticals | 0.2 | $3.8M | 182k | 20.80 | |
Juno Therapeutics | 0.2 | $3.7M | 197k | 18.85 | |
Kite Pharma | 0.2 | $3.5M | 79k | 44.84 | |
Innoviva (INVA) | 0.2 | $3.6M | 337k | 10.70 | |
Medicines Company conv | 0.2 | $3.6M | 3.0M | 1.20 | |
Cardiome Pharma | 0.2 | $3.3M | 1.2M | 2.76 | |
Otonomy | 0.2 | $3.3M | 210k | 15.90 | |
Ariad Pharmaceuticals | 0.2 | $3.1M | 250k | 12.44 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $3.1M | 300k | 10.40 | |
Nabriva Therapeutics | 0.2 | $3.1M | 525k | 5.95 | |
Puma Biotechnology (PBYI) | 0.2 | $2.9M | 95k | 30.70 | |
Tetraphase Pharmaceuticals | 0.2 | $2.8M | 698k | 4.03 | |
Intra Cellular Therapies (ITCI) | 0.2 | $2.9M | 190k | 15.09 | |
Hill-Rom Holdings | 0.2 | $2.7M | 48k | 56.15 | |
Adaptimmune Therapeutics (ADAP) | 0.2 | $2.7M | 675k | 4.05 | |
Exelixis (EXEL) | 0.2 | $2.6M | 175k | 14.91 | |
Dbv Technologies S A | 0.2 | $2.6M | 73k | 35.12 | |
Madrigal Pharmaceuticals (MDGL) | 0.2 | $2.6M | 175k | 14.90 | |
Rigel Pharmaceuticals | 0.2 | $2.4M | 1.0M | 2.38 | |
Scynexis | 0.2 | $2.4M | 760k | 3.19 | |
Zimmer Holdings (ZBH) | 0.1 | $2.2M | 21k | 103.22 | |
Egalet | 0.1 | $2.3M | 300k | 7.65 | |
Seres Therapeutics (MCRB) | 0.1 | $2.2M | 220k | 9.90 | |
Aeglea Biotherapeutics | 0.1 | $2.3M | 524k | 4.35 | |
Healthequity (HQY) | 0.1 | $2.0M | 50k | 40.52 | |
Genocea Biosciences | 0.1 | $2.0M | 480k | 4.12 | |
Bluebird Bio (BLUE) | 0.1 | $1.8M | 29k | 61.68 | |
Novocure Ltd ord (NVCR) | 0.1 | $1.7M | 214k | 7.85 | |
Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $1.7M | 1.5M | 1.14 | |
Tandem Diabetes Care | 0.1 | $1.3M | 595k | 2.15 | |
Global Blood Therapeutics In | 0.1 | $1.4M | 97k | 14.45 | |
Dimension Therapeutics | 0.1 | $1.2M | 271k | 4.35 | |
Novavax | 0.1 | $1.0M | 820k | 1.26 | |
Valeant Pharmaceuticals Int | 0.1 | $1.0M | 71k | 14.52 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.0M | 475k | 2.15 | |
Nivalis Therapeutics | 0.1 | $1.1M | 489k | 2.24 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $1.1M | 1.0M | 1.05 | |
Myovant Sciences | 0.1 | $1.1M | 90k | 12.44 | |
Chiasma | 0.1 | $960k | 493k | 1.95 | |
Perrigo Company (PRGO) | 0.1 | $774k | 9.3k | 83.23 | |
Dynavax Technologies (DVAX) | 0.0 | $652k | 165k | 3.95 | |
Cerulean Pharma | 0.0 | $444k | 625k | 0.71 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $365k | 270k | 1.35 | |
Anthera Pharmaceutcls | 0.0 | $247k | 380k | 0.65 | |
Orexigen Therapeutics | 0.0 | $288k | 165k | 1.74 |